Axon (NASDAQ: AXON) holder files to potentially sell 1,000 shares
Rhea-AI Filing Summary
A shareholder of Axon (AXON) filed to potentially sell 1,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on or after August 4, 2026 on NASDAQ. The securities include shares from restricted stock vesting of 343 shares on May 13, 2024 and 657 shares on May 10, 2025, both granted for services rendered under a registered plan.
Positive
- None.
Negative
- None.
Key Figures
Shares Proposed for Sale: 1,000 shares
Aggregate Value of Shares: $599,445.10
Planned Sale Date: 08/04/2026
+2 more
5 metrics
Shares Proposed for Sale
1,000 shares
Common stock to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services
Aggregate Value of Shares
$599,445.10
Market value associated with the 1,000 shares of common stock
Planned Sale Date
08/04/2026
Date listed for potential sale of common stock on NASDAQ
Restricted Stock Vesting 2024
343 shares
Restricted stock vesting under a registered plan on 05/13/2024 for services rendered
Restricted Stock Vesting 2025
657 shares
Restricted stock vesting under a registered plan on 05/10/2025 for services rendered
Key Terms
Form 144, Restricted Stock Vesting Under a Registered Plan, Services Rendered, Executive Financial Services
4 terms
Form 144 regulatory
"Filer Information | | | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Restricted Stock Vesting Under a Registered Plan financial
"Common | 05/13/2024 | Restricted Stock Vesting Under a Registered Plan"
Services Rendered financial
"343 | 05/13/2024 | Services Rendered Common | 05/10/2025"
Executive Financial Services financial
"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Axon (AXON) report in this Form 144 filing?
A shareholder plans a potential sale of 1,000 Axon common shares through Morgan Stanley Smith Barney LLC Executive Financial Services, with the shares expected to be sold on or after August 4, 2026 on NASDAQ.
What restricted stock awards are referenced for Axon (AXON) in this filing?
The filing references restricted stock vesting of 343 shares on May 13, 2024 and 657 shares on May 10, 2025, both described as restricted stock vesting under a registered plan for services rendered.